Did Lacrifill® meet the primary effectiveness endpoint?
Yes. Lacrifill® was statistically non-inferior to the hydrogel plug for [...]
What was the primary effectiveness endpoint?
The primary endpoint assessed whether Lacrifill® was non-inferior to the [...]
Which patients were enrolled in the study?
Eligible patients were adults aged 22 years or older with [...]
How many patients participated in the pivotal clinical study?
A total of 157 patients were randomised in a 2:1 [...]
What clinical evidence supports Lacrifill®?
Lacrifill® was evaluated in a prospective, multicentre, controlled, double-masked, randomised [...]
Where is Lacrifill® intended to be administered?
Lacrifill® is intended for use in an appropriate clinical environment, [...]
How long can my patients expect symptom relief after Lacrifill® treatment?
Lacrifill® has been shown to provide relief from symptoms of [...]
Can Lacrifill® affect the action of topical ocular medication?
As with other punctal or canalicular occlusion devices, Lacrifill® may [...]
Has Lacrifill® been evaluated with cyclosporine or lifitegrast treatment?
Clinical performance has not been established in patients who used [...]
Has Lacrifill® been evaluated in children or during pregnancy?
Clinical performance has not been established in paediatric patients or [...]